Skip to main content

and
  1. Article

    Open Access

    Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

    Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life...

    Ana Fernández, Mercedes Salgado, Adelaida García, Elvira Buxò, Ruth Vera in BMC Cancer (2018)